Literature DB >> 12218776

Biodistribution and retention time of retrovirally labeled T lymphocytes in mice is strongly influenced by the culture period before infusion.

Sebastianus Kolen1, Harry Dolstra, Louis van de Locht, Eric Braakman, Anton Schattenberg, Theo de Witte, Elly van de Wiel-van Kemenade.   

Abstract

T lymphocytes used for adoptive immunotherapy are often cultured before transfer to generate sufficient amounts of effector cells with desired specificity. Modification of lymphocytes induced by in vitro activation and expansion may influence their potential effector capacity by altering the survival and trafficking patterns after transfer. In this report, the authors show that the culture period of T cells after ConA/IL-2 stimulation strongly influences the retention and tissue distribution of these cells after infusion into syngeneic C57BL/6 mice. Infused labeled cells that have been cultured for 3 days remained in the peripheral blood and organs in at least a ten-fold higher number than cells cultured for 8 days. In addition, cells cultured for 3 days preferentially migrate to lungs and liver shortly after infusion and subsequently to lymph nodes and spleen. Cells cultured for 8 days preferentially migrate to liver and can be hardly detected in lymph nodes. In contrast, labeled cells cultured for 3 days are predominantly present in lymph nodes starting from day 8 until day 28. We showed that accurate monitoring of transferred cells is feasible, which may contribute to understanding response to adoptive immunotherapy.

Entities:  

Mesh:

Year:  2002        PMID: 12218776     DOI: 10.1097/00002371-200209000-00002

Source DB:  PubMed          Journal:  J Immunother        ISSN: 1524-9557            Impact factor:   4.456


  5 in total

1.  Immunotherapy through T-cell receptor gene transfer induces severe graft-versus-host disease.

Authors:  James Ferrara; Pavan Reddy; Sophie Paczesny
Journal:  Immunotherapy       Date:  2010-11       Impact factor: 4.196

2.  Lethal graft-versus-host disease in mouse models of T cell receptor gene therapy.

Authors:  Gavin M Bendle; Carsten Linnemann; Anna I Hooijkaas; Laura Bies; Moniek A de Witte; Annelies Jorritsma; Andrew D M Kaiser; Nadine Pouw; Reno Debets; Elisa Kieback; Wolfgang Uckert; Ji-Ying Song; John B A G Haanen; Ton N M Schumacher
Journal:  Nat Med       Date:  2010-04-18       Impact factor: 53.440

3.  T cells enhance gold nanoparticle delivery to tumors in vivo.

Authors:  Laura C Kennedy; Adham S Bear; Joseph K Young; Nastassja A Lewinski; Jean Kim; Aaron E Foster; Rebekah A Drezek
Journal:  Nanoscale Res Lett       Date:  2011-04-04       Impact factor: 4.703

4.  CMV-specific T cell isolation from G-CSF mobilized peripheral blood: depletion of myeloid progenitors eliminates non-specific binding of MHC-multimers.

Authors:  Lorea Beloki; Miriam Ciaurriz; Cristina Mansilla; Amaya Zabalza; Estela Perez-Valderrama; Edward R Samuel; Mark W Lowdell; Natalia Ramirez; Eduardo Olavarria
Journal:  J Transl Med       Date:  2014-11-19       Impact factor: 5.531

5.  SILAC-based chemoproteomics reveals a neoligan analogue as an anti-inflammatory agent targeting IRGM to ameliorate cytokine storm.

Authors:  Jichao Zhang; Yang Li; Guibing Meng; Kui Lu; Jiankun Yan; Jiangpeng Wu; Pengyan Li; Lingling Luo; Xi Chen; Xia Zhao; Feng Qiu
Journal:  Eur J Med Chem       Date:  2022-08-08       Impact factor: 7.088

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.